TY  - GEN
AU  - Kostev,Karel
AU  - Schokker,Emile
AU  - Jacob,Louis
TI  - Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings

SN  - 0946-1965
PY  - 2019///0503
KW  - Adamantane
KW  - analogs & derivatives
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Biomarkers
KW  - blood
KW  - Blood Glucose
KW  - drug effects
KW  - Clinical Decision-Making
KW  - Databases, Factual
KW  - Diabetes Mellitus, Type 2
KW  - Dipeptides
KW  - therapeutic use
KW  - Dipeptidyl Peptidase 4
KW  - metabolism
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - Female
KW  - Germany
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Patient Selection
KW  - Practice Patterns, Physicians'
KW  - Randomized Controlled Trials as Topic
KW  - Sex Factors
KW  - Sitagliptin Phosphate
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vildagliptin
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.5414/CP203285
ER  -